-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Background to Virally Driven Lymphoproliferative Disorders

Symposia: Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities Program: Scientific Workshops
Friday, December 8, 2023: 2:03 PM-2:43 PM
Room 8 (San Diego Convention Center)
Moderator:
and Helen Elisabeth Heslop, Baylor College of Medicine
Disclosures:
Heslop: Marker Therapeutics: Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees; Tessa Therapeutics: Membership on an entity's Board of Directors or advisory committees, Other: Research Support; Ankyra Therapeutics: Membership on an entity's Board of Directors or advisory committees; Allovir: Current equity holder in private company; Fresh Wind Biotechnologies: Current equity holder in private company; CoRegen Inc.: Current equity holder in private company.
see info provided by Dr Gandhi
Moderator Introduction

Helen Elisabeth Heslop

Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX
An Update on Classification

Elaine S. Jaffe, MD

CCR Lab of Pathology, National Cancer Institute, Bethesda, MD
Epstein-Barr Virus T Cell Immunity and Genetic Susceptibility

Keri Toner, MD

Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC
Epstein-Barr Virus + Diffuse Large B-cell Lymphoma – The Old and Not So Old

Fabian Frontzek

Department of Lymphoid Cancer Research, BC Cancer Research Centre, Vancouver, BC, Canada
Panel Discussion
See more of: Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities
See more of: Scientific Workshops
<< Previous Session | Next Session >>